F-18-FDG-PET for differential diagnosis of pleural processes;F-18-fdg-pet zur primaerdiagnostik und dignitatsbeurteilung pleuraler prozesse

NuklearMedizin

Volumn 38, Issue 8, 1999, Pages 319-322

  Buchmann, Inga ^a   Guhlmann, C A ^b   Elsner, K ^b   Gfrorer W ^b   Schirrmeister, H ^b   Kotzerke, J ^b   Buck, A ^b   Reske, S N ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b NONE

Author keywords

Carcinomatous pleurisy; FDG PET; Pleural biopsy; Pleural effusion; Pleural mesothelioma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LUNG ADENOCARCINOMA; MALE; PLEURA DISEASE; PLEURA MESOTHELIOMA; PLEURISY; POSITRON EMISSION TOMOGRAPHY; SYMPTOMATOLOGY;

EID: 0032764542     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1632229     Document Type: Article

References (15)

1. Muller N. Imaging of the pleura. Radiology 1993; 186: 297-309.
2. Leung AN, Müller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR1990; 154: 487-92.
3. Falaschi F, Battolla L, Mascalchi M et al. Usefulness of MR signal intensity in distinguishing benign from malignant pleural disease. AJR 1996; 166: 963-8.
4. Sahn S. Malignant pleural effusions. In: Pulmonary diseases and disorders 1988. Fischman AP (ed). 2nd edition. New York: McGraw-Hill 1988; 2159-70.
5. Trampert L, Holle LH, Berberich R, Alexander C et al. FDG in the primary staging of lung tumors. Results with a gamma camera and a 511 keV collimator. Nuklearmedizin 1995; 34(3): 79-86.
6. Reske SN, Bares R, Büll U, Guhlmann A, Moser E, Wannenacher MF. Klinische Wertigkeit der Positronen-Emissions-Tomographie (PET) bei onkologischen Fragestellungen: Ergebnisse einer interdisziplinären Konsensuskonferenz. Nuklearmedizin 1996; 35: 42-52.
7. Dewan N, Gupta N, Redepenning L, Phalen J, Frick M. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Chest 1993; 104: 997-1002.
8. Guhlmann A, Storck M. Kotzerke J et al. Lymph node staging in non-small cell lung cancer: evaluation by (F-18)FDG positron emission tomography (PET). Thorax 1997; 52: 438-41.
9. Wahl R, Quint I, Greenough R, Meyer C, White R, Orringer M. Staging of mediastinal non-small cell lung cancer with FDG-PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994; 191: 371-7.
10. Schmidlin P. Improved iterative image reconstruction using variable projection binning and abbreviated convolution. Eur J Nucl Med 1994; 21: 930-6.
11. Canto A, Arnau A, Galbis J et al. The so-called malignant pleural effusion: A new review of direct data obtained with diagnostic pleurascopy. Arch Bronchopneumol 1996; 32(9): 453-8
12. Hansen M, Faurschou P, Clementsen P. Medical thoracoscopy, results and complications in 146 patients: a retrospective study. Respir Med 1998; 92(2):228-32.
13. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-14.
14. Bury TH, Paulus P, Dowlati A, Corhay JL et al. Evaluation of pleural disease with FDG-PET imaging: Preliminary report. Thorax 1997; 52: 187-9.
15. Bernard F, Sterman D, Smith RJ et al. Metabolic imaging of malignant pleural mesothelioma with Fluorodeoxyglucose positron emission tomography. Chest 1998; 114(3): 713-22.